Laser Ablation: After a small incision, hair and debris removal, and curettage, laser ablation is performed using a Leonardo Mini 1470 nm diode laser.
Crystallized phenol application: After a small incision, hair and debris removal, and curettage, crystallized phenol is applied to the sinus cavity.
Study summary
This single-center prospective randomized parallel-group trial compares laser ablation and crystallized phenol application in adults with primary uncomplicated sacrococcygeal pilonidal sinus disease. The primary objective is to compare postoperative day 1 pain intensity between the two treatment methods. Secondary objectives include complete epithelialization by day 30, time to complete epithelialization, postoperative day 7 pain, duration of analgesic use, time to return to daily activities and work, early local complications, and 6-month recurrence.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age 18 years or older
* Diagnosis of primary chronic sacrococcygeal pilonidal sinus disease
* Uncomplicated disease
* Suitability for minimally invasive treatment
* Provision of written informed consent
Exclusion Criteria:
* Acute pilonidal abscess
* History of pilonidal abscess drainage
* Previous surgical or interventional treatment for pilonidal sinus disease
* Recurrent pilonidal disease
* Complex pilonidal disease or marked lateral extension
* Immunosuppression, chronic steroid use, or systemic conditions that may significantly impair wound healing
* Inability to attend regular follow-up
* Refusal to participate in the study
Primary outcome measure(s)
Postoperative day 1 pain score — Postoperative day 1 Pain intensity on postoperative day 1 assessed using a 0 to 10 Visual Analog Scale, where 0 indicates no pain and 10 indicates the worst imaginable pain; higher scores indicate worse pain.
Trial sites (1)
Facility
City
Region
Status
Sanliurfa Education and Research Hospital
Sanliurfa
Şanlıurfa
Recruiting
More Sanliurfa Education and Research Hospital trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.